Analyze Diet

Topic:Immunization

Immunization in horses involves the administration of vaccines to stimulate an immune response, thereby providing protection against specific infectious diseases. Vaccines commonly used in equine medicine include those for equine influenza, tetanus, and West Nile virus. The process of immunization aims to prepare the horse's immune system to recognize and combat pathogens upon exposure. Vaccination schedules and protocols may vary based on factors such as age, health status, and regional disease prevalence. This page compiles peer-reviewed research studies and scholarly articles that explore the mechanisms, efficacy, and considerations of immunization practices in equine health.
Enhanced immune effects and protection conferred by simultaneously targeting GAPDH, SeM, and EAG of S. equi via TLR4.
Research in veterinary science    June 8, 2021   Volume 138 100-108 doi: 10.1016/j.rvsc.2021.06.001
Chen X, Zhao Y, Su L, Wang L, Ma X, Zhang B, Su Y.Strangles, which is caused by Streptococcus equi subspecies equi, is one of the most prevalent equine infectious diseases and poses heavy economic losses worldwide. Although various vaccines have been used for decades, they seemed to be sub-optimal to demonstrate effective protection, and the antigen component of vaccines against S. equi remains to be optimized. In the present study, three target antigens (M-like protein, α2-macroglobulin and IgG-binding protein, and glyceraldehyde-3-phosphate dehydrogenase) were selected and expressed. Mice were immunized and challenged, and their immune res...
Prophylactic Efficacy of Equine Immunoglobulin F(ab’)2 Fragments Against Feline Parvovirus.
Applied biochemistry and biotechnology    June 4, 2021   Volume 193, Issue 10 3151-3162 doi: 10.1007/s12010-021-03591-z
Liu J, Zhang Z, Bai A, Sha Y, Ma L, Qin S, Chen F, Qin S, Wu J.Feline parvovirus (FPV), a type of parvovirus prevalent worldwide, can cause foetal death and acute enteritis in adult cats with severe leukopenia, and yet there are no effective drugs to prevent or treat FPV. Here, the immune effects of two FPV vaccines on horses were compared. IgG was extracted from FPV-immunized horse sera. Equine F(ab') fragments were obtained from pepsin-digested IgG and then purified by protein-G column chromatography. The results showed that the inactivated FPV oil vaccine was more effective than the inactivated FPV propolis vaccine in helping healthy horses to produce ...
Preparation and evaluation of virus-like particle vaccine against H3N8 subtype equine influenza.
Microbial pathogenesis    May 12, 2021   Volume 157 104885 doi: 10.1016/j.micpath.2021.104885
Zhang P, Sun Y, Tan C, Ling M, Li X, Wang W, Cong Y.To prevent and control H3N8 subtype equine influenza, we prepared virus-like particles (VLPs) comprising the HA, NA and M1 proteins of H3N8 equine influenza virus (EIV) through the insect cell-baculovirus expression system. The results of Western blot and hemagglutination analyses demonstrated that the constructed VLPs comprising HA, NA and M1 proteins have good hemagglutination activity. Immunoelectron microscope revealed that the VLPs share similar morphology and structure with natural virus particles. The hyperimmune serum from horses immunized with the VLPs were injected into mice by means...
In vitro Inhibitory Activity of IgY Antibodies Against Salmonella Ser. Newport Isolated from Horses.
Journal of equine veterinary science    May 12, 2021   Volume 103 103657 doi: 10.1016/j.jevs.2021.103657
Bustos CP, Leiva CL, Gambarotta M, Guida N, Chacana PA.Equine salmonellosis is caused by several Salmonella serotypes, including Salmonella Newport, which cause enterocolitis and diarrhea. Treatment usually includes the administration of antibiotics. However, since multidrug-resistant Salmonella is commonly detected, alternative options to control the pathogen are needed. One of these options is the use of specific egg yolk antibodies (IgY) for passive immunotherapy. Thus, the aim of our work was to produce IgY antibodies against an equine S. Newport strain and assess their in vitro inhibitory activity. To this end, laying hens were immunized with...
Development and characterization of two equine formulations towards SARS-CoV-2 proteins for the potential treatment of COVID-19.
Scientific reports    May 10, 2021   Volume 11, Issue 1 9825 doi: 10.1038/s41598-021-89242-z
León G, Herrera M, Vargas M, Arguedas M, Sánchez A, Segura Á, Gómez A, Solano G, Corrales-Aguilar E, Risner K, Narayanan A, Bailey C, Villalta M....In the current global emergency due to SARS-CoV-2 outbreak, passive immunotherapy emerges as a promising treatment for COVID-19. Among animal-derived products, equine formulations are still the cornerstone therapy for treating envenomations due to animal bites and stings. Therefore, drawing upon decades of experience in manufacturing snake antivenom, we developed and preclinically evaluated two anti-SARS-CoV-2 polyclonal equine formulations as potential alternative therapy for COVID-19. We immunized two groups of horses with either S1 (anti-S1) or a mixture of S1, N, and SEM mosaic (anti-Mix) ...
Theileria equi claudin like apicomplexan microneme protein contains neutralization-sensitive epitopes and interacts with components of the equine erythrocyte membrane skeleton.
Scientific reports    April 29, 2021   Volume 11, Issue 1 9301 doi: 10.1038/s41598-021-88902-4
Onzere CK, Fry LM, Bishop RP, Silva MG, Bastos RG, Knowles DP, Suarez CE.Theileria equi is a widely distributed apicomplexan parasite that causes severe hemolytic anemia in equid species. There is currently no effective vaccine for control of the parasite and understanding the mechanism that T. equi utilizes to invade host cells may be crucial for vaccine development. Unlike most apicomplexan species studied to date, the role of micronemes in T. equi invasion of host cells is unknown. We therefore assessed the role of the T. equi claudin-like apicomplexan microneme protein (CLAMP) in the invasion of equine erythrocytes as a first step towards understanding the role...
Hemagglutinin inhibition antibody responses to commercial equine influenza vaccines in vaccinated horses.
The Canadian veterinary journal = La revue veterinaire canadienne    March 12, 2021   Volume 62, Issue 3 266-272 
Karam B, Wilson WD, Chambers TM, Reedy S, Pusterla N.The use of a hemagglutination inhibition (HI) assay to assess humoral immune response to equine influenza virus (EIV) vaccines from various manufacturers administered to previously immunized adult horses was investigated. Subjects were allocated into one of 3 groups and vaccinated with various commercially available vaccines. Groups were subdivided into subjects that received 1 dose of a particular vaccine and those that received a second dose, 30 d later. Serum was collected at various times to assess antibody responses to contemporary EIV Florida sub-lineage strains. Statistical significance...
Growth properties and immunogenicity of a virus generated by reverse genetics for an inactivated equine influenza vaccine.
Equine veterinary journal    February 18, 2021   Volume 54, Issue 1 139-144 doi: 10.1111/evj.13431
Ohta M, Bannai H, Kambayashi Y, Tamura N, Tsujimura K, Yamayoshi S, Kawaoka Y, Nemoto M.Keeping vaccine strains up to date is the key to controlling equine influenza (EI). Viruses generated by reverse genetics (RG) are likely to be effective for quickly updating a vaccine strain. Objective: To evaluate the growth properties of an RG virus in embryonated chicken eggs, and to evaluate antibody responses to a formalin-inactivated vaccine derived from the RG virus in Thoroughbred horses. Methods: In vitro and in vivo experiments. Methods: Wild-type (WT) viruses (A/equine/Ibaraki/1/2007) or RG viruses (consisting of haemagglutinin [HA] and neuraminidase genes derived from A/equine/Iba...
Immunogenicity of Calvenza-03 EIV/EHV® Vaccine in Horses: Comparative In Vivo Study.
Vaccines    February 17, 2021   Volume 9, Issue 2 166 doi: 10.3390/vaccines9020166
Pavulraj S, Bergmann T, Trombetta CM, Marchi S, Montomoli E, Alami SSE, Ragni-Alunni R, Osterrieder N, Azab W.Equine influenza (EI) is a highly contagious acute respiratory disease of equines that is caused mainly by the H3N8 subtype of influenza A virus. Vaccinating horses against EI is the most effective strategy to prevent the infection. The current study aimed to compare the kinetics of EI-specific humoral- and cell-mediated immunity (CMI) in horses receiving either identical or mixed vaccinations. Two groups of horses were previously (six months prior) vaccinated with either Calvenza 03 EIV EHV (G1) or Fluvac Innovator (G2) vaccine. Subsequently, both groups received a booster single dose of Calv...
Modulation of Serum Protein Electrophoretic Pattern and Leukocyte Population in Horses Vaccinated against West Nile Virus.
Animals : an open access journal from MDPI    February 11, 2021   Volume 11, Issue 2 477 doi: 10.3390/ani11020477
Arfuso F, Giudice E, Di Pietro S, Piccione G, Giannetto C.This study aimed to evaluate the hematological and serum protein electrophoretic profiles of horses after inactivated West Nile virus (WNV) vaccine administration. Blood samples were collected from 10 horses before (T0), after 24 h, 48 h, 72 h, 1 week, 2 weeks and 3 weeks (T1, T2, T3, T4, T5 and T6) from the first WNV vaccine-dose administration, before the vaccine-booster (TPRE), and after 24 h, 48 h, 72 h, 1 week, 2 weeks and 3 weeks (T1, T2, T3, T4, T5, T6) from the WNV vaccine-booster. There was a significant increase in lymphocytes and a decrease in neutrophils after both the first vaccin...
Evaluation of Antibody Response in Horses After Vaccination With an Inactivated Getah Virus Vaccine Using an Accelerated Immunization Schedule.
Journal of equine veterinary science    February 3, 2021   Volume 99 103396 doi: 10.1016/j.jevs.2021.103396
Bannai H, Tominari M, Kambayashi Y, Nemoto M, Tsujimura K, Ohta M.Antibody response in horses after accelerated-schedule Getah virus vaccination was evaluated for its potential adoption during outbreaks. One-year-old Thoroughbred horses received two doses of priming vaccinations following an accelerated schedule (accelerated group: 14-day interval, n = 30) or the conventional schedule (control group: 28-day interval, n = 30). At Day 14, both groups showed similar seropositive rates (66.7% in control group and 73.3% in accelerated group) and geometric mean (GM) virus-neutralizing titers (5.2 [95% confidence interval (CI), 3.0-8.8] in control group and 5.3...
Effects of srtA variation on phagocytosis resistance and immune response of Streptococcus equi.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases    January 24, 2021   Volume 89 104732 doi: 10.1016/j.meegid.2021.104732
Zhang H, Zhou T, Su L, Wang H, Zhang B, Su Y.Strangles, which is caused by Streptococcus equi subspecies equi (S. equi), is one of the most prevalent equine infectious diseases with worldwide distribution and leads to serious economic loss in the horse industry. Sortase A (srtA) is a transpeptidase that anchors multiple virulence-associated surface proteins to the cell surface of S. equi. srtA plays a major role in S. equi infection and colonization of the host cell. In this study, we aimed to investigate the effects of srtA mutation on the phagocytic activity and immunogenicity of S. equi. The point-mutated recombinant sortases, includi...
Vaccination against GnRH as a prelude to surgical castration of horses.
Equine veterinary journal    January 20, 2021   Volume 53, Issue 6 1141-1149 doi: 10.1111/evj.13411
Birrell JR, Schulman ML, Botha AE, Ganswindt A, Fosgate GT, Bertschinger HJ.Surgical castration is one of the most frequently performed surgeries in horses and is associated with various post-surgical complications ranging in severity. Objective: We investigated the effects of administering an anti-GnRH vaccine to colts for reduction of testis size on the incidence of complications associated with their subsequent surgical castration. Methods: Randomised open controlled trial. Methods: Nineteen colts were randomly assigned to one of the three groups. Treatment Groups V1-57 and V2-100 received two treatments of Improvac (Zoetis, South Africa) before their castration in...
Humoral and cell-mediated immune responses to plant-produced African horse sickness virus VP7 quasi-crystals.
Virus research    January 6, 2021   Volume 294 198284 doi: 10.1016/j.virusres.2020.198284
Fearon SH, Dennis SJ, Hitzeroth II, Rybicki EP, Meyers AE.African horse sickness (AHS) is a devastating viral disease affecting equines and has resulted in many disastrous epizootics. To date, no successful therapeutic treatment exists for AHS, and commercially used live-attenuated vaccines have various undesirable side effects. Previous studies have shown that mice inoculated with insoluble African horse sickness virus (AHSV) VP7 crystals are protected from live challenge with a lethal dose of AHSV. This study investigates the humoral and cell-mediated immune responses in guinea-pigs to a safer monovalent vaccine alternative based on AHSV-5 VP7 quas...
Animal and Human Vaccines against West Nile Virus.
Pathogens (Basel, Switzerland)    December 21, 2020   Volume 9, Issue 12 1073 doi: 10.3390/pathogens9121073
Saiz JC.West Nile virus (WNV) is a widely distributed enveloped flavivirus transmitted by mosquitoes, which main hosts are birds. The virus sporadically infects equids and humans with serious economic and health consequences, as infected individuals can develop a severe neuroinvasive disease that can even lead to death. Nowadays, no WNV-specific therapy is available and vaccines are only licensed for use in horses but not for humans. While several methodologies for WNV vaccine development have been successfully applied and have contributed to significantly reducing its incidence in horses in the US, n...
Case Report: Suppression of Harem Stallion Behavior and Fertility Following Anti-Gonadotropin-Releasing Hormone Vaccination of a Captive Wild Przewalski’s Horse (Equus ferus przewalskii).
Frontiers in veterinary science    November 24, 2020   Volume 7 569185 doi: 10.3389/fvets.2020.569185
Ponthier J, Rigaux G, Parrilla-Hernandez S, Egyptien S, Gatez C, Carrasco Leroy C, Deleuze S.This report describes an option to modulate the testicular function of wild horses and field methods to assess it. Non-surgical castration of a captive wild Przewalski's stallion with anti-gonadotropin-releasing hormone (GnRH) immunization was performed by sub-cutaneous injection of two doses of 450 μg (3 ml) of GnRH conjugated to diphtheria toxin, further repeated every 6 months. Semen quality was assessed after collection by electro-ejaculation under general anesthesia. Endocrine and behavioral consequences were studied during a 2-year follow-up period. The procedure of electro-ejaculation ...
Evaluation of Colostral Immunity Against Equine Herpesvirus Type 1 (EHV-1) in Martina Franca’s Foals.
Frontiers in veterinary science    November 23, 2020   Volume 7 579371 doi: 10.3389/fvets.2020.579371
Di Francesco CE, Smoglica C, De Amicis I, Cafini F, Carluccio A, Contri A.Eight Martina Franca pregnant jennies were selected in order to evaluate the transfer of colostral antibodies against equine herpesvirus type 1 in their relative foals after immunization with a commercial inactivated vaccine, compared with an unvaccinated group. Samples of serum and colostrums/milk were collected from jennies and foals under study starting from 10 min before and up to 21 days after the foaling. Specific anti-EHV-1 antibody titers were evaluated by means of a serum neutralization test, and the results obtained from both groups were analyzed. The serological titers in the vaccin...
Developmental Results of a Vaccine against Salmonella-Induced Equine Abortion.
Russian agricultural sciences    November 4, 2020   Volume 46, Issue 5 530-533 doi: 10.3103/S1068367420050158
Neustroev MP, Petrova SG.An inactivated vaccine based on the BN-12 strain with the TNP-3 strain filtrate used as immunomodulator has been developed in order to prevent salmonella-induced equine abortion. Preclinical and clinical trials with the white mice and the horses, respectively, are carried out. The lack of toxicity is proven. The vaccine immunogenicity for mouse and mare models comprised 90 and 100%, respectively. The industrial vaccine tests showed that the industrial output of foals increased by 13.8% after immunization. Cost-effectiveness of the vaccine used with the TNP-3 strain filtrate comprised 14.1 r...
Humoral antibody response of 10 horses after vaccination against African horse sickness with an inactivated vaccine containing all 9 serotypes in one injection.
Equine veterinary journal    October 29, 2020   Volume 53, Issue 4 826-833 doi: 10.1111/evj.13363
Wernery U, Rodriguez M, Raghavan R, Syriac G, Miriam Thomas M S, Elizabeth SK, Federico Ronchi G, Muhammed R, Patteril NA, Joseph S.African horse sickness (AHS) is a devastating viral disease of equids that was first recorded in 1327. Currently, prevention and control of the disease are based on attenuated vaccines and midge control. It has been shown that attenuated Orbivirus vaccines are not always safe as they may reverse to virulence. Objective: In the Emirate of Dubai, a vaccination experiment was carried out with an inactivated AHS vaccine produced at the Central Veterinary Research Laboratory (CVRL), Dubai, UAE to investigate the humoral antibody response of AHS-naïve horses to this vaccine. Our vaccination experim...
Vaccination of yearling horses against poly-N-acetyl glucosamine fails to protect against infection with Streptococcus equi subspecies equi.
PloS one    October 15, 2020   Volume 15, Issue 10 e0240479 doi: 10.1371/journal.pone.0240479
Cohen ND, Cywes-Bentley C, Kahn SM, Bordin AI, Bray JM, Wehmeyer SG, Pier GB.Strangles is a common disease of horses with worldwide distribution caused by the bacterium Streptococcus equi subspecies equi (SEE). Although vaccines against strangles are available commercially, these products have limitations in safety and efficacy. The microbial surface antigen β 1→6 poly-N-acetylglucosamine (PNAG) is expressed by SEE. Here we show that intramuscular (IM) injection alone or a combination of IM plus intranasal (IN) immunization generated antibodies to PNAG that functioned to deposit complement and mediate opsonophagocytic killing of SEE ex vivo. However, immunization st...
Active immunisation against GnRH as treatment for unilateral granulosa theca cell tumour in mares.
Equine veterinary journal    October 2, 2020   Volume 53, Issue 4 740-745 doi: 10.1111/evj.13352
Behrendt D, Burger D, Gremmes S, Szunyog K, Röthemeier S, Sieme H.Stallion-like or aggressive behaviour in mares affected by unilateral granulosa theca cell tumour (GTCT) is well-known, but use of a GnRH-vaccine as an alternative to surgical removal of the neoplastic ovary has not been investigated. Objective: To determine the effect of immunisation against GnRH on ovarian size, testosterone concentration, Anti-Müllerian hormone (AMH) concentration, and owner-reported behaviour in four mares affected by unilateral GTCT. Methods: Retrospective case report. Methods: A presumptive diagnosis of GTCT was made in four mares based on clinical signs, behavioural ch...
Multicomponent gold nano-glycoconjugate as a highly immunogenic and protective platform against Burkholderia mallei.
NPJ vaccines    September 10, 2020   Volume 5 82 doi: 10.1038/s41541-020-00229-9
Tapia D, Sanchez-Villamil JI, Torres AG.Burkholderia mallei (Bm) is a facultative intracellular pathogen and the etiological agent of glanders, a highly infectious zoonotic disease occurring in equines and humans. The intrinsic resistance to antibiotics, lack of specific therapy, high mortality, and history as a biothreat agent, prompt the need of a safe and effective vaccine. However, the limited knowledge of protective Bm-specific antigens has hampered the development of a vaccine. Further, the use of antigen-delivery systems that enhance antigen immunogenicity and elicit robust antigen-specific immune responses has been limited a...
Safety and efficacy of inactivated African horse sickness (AHS) vaccine formulated with different adjuvants.
Vaccine    September 10, 2020   Volume 38, Issue 45 7108-7117 doi: 10.1016/j.vaccine.2020.08.072
van Rijn PA, Maris-Veldhuis MA, Grobler M, Wright IM, Erasmus BJ, Maartens LH, Potgieter CA.African horse sickness virus (AHSV) is a virus species in the genus Orbivirus of the family Reoviridae causing African Horse Sickness (AHS) in equids with a mortality of about 95% in naïve horses. AHS causes serious losses in developing countries where horses play a central role in draft power and transportation. There are nine AHSV serotypes inducing no or low cross-neutralizing antibodies. AHSV is spread by biting Culicoides midges. AHS is endemic in sub-Saharan Africa, and a serious threat outside Africa, since Culicoides species in moderate climate conditions are spreading the closely rel...
Rationally Attenuated Vaccines for Venezuelan Equine Encephalitis Protect Against Epidemic Strains with a Single Dose.
Vaccines    September 2, 2020   Volume 8, Issue 3 497 doi: 10.3390/vaccines8030497
Rossi SL, Russell-Lodrigue KE, Plante KS, Bergren NA, Gorchakov R, Roy CJ, Weaver SC.Venezuelan equine encephalitis virus (VEEV) is a re-emerging virus of human, agriculture, and bioweapon threat importance. No FDA-approved treatment is available to combat Venezuelan equine encephalitis in humans, prompting the need to create a vaccine that is safe, efficacious, and cannot be replicated in the mosquito vector. Here we describe the use of a serotype ID VEEV (ZPC-738) vaccine with an internal ribosome entry site (IRES) to alter gene expression patterns. This ZPC/IRES vaccine was genetically engineered in two ways based on the position of the IRES insertion to create a vaccine th...
Whole-Blood Validation of a New Point-of-care Equine Serum Amyloid A Assay.
Journal of equine veterinary science    August 15, 2020   Volume 94 103222 doi: 10.1016/j.jevs.2020.103222
Karam B, Hines S, Skipper L, Pusterla N.Serum amyloid A (SAA) is considered a major acute phase protein (APP) in horses. Serum amyloid A stall-side assays are commercially available to assess the inflammatory response of patients with various infectious and noninfectious conditions. The objective of this study was to determine the analytical performance of a new point-of-care (POC) assay for the measurement of SAA in whole blood and plasma of horses. One hundred and sixty blood samples were collected from 60 horses at various time points after immunization with an equine core vaccine. Analytical validation of the SAA POC assay inclu...
Genotype-specific neutralizing antibody titers against Japanese encephalitis virus genotypes 1 and 3 in horses immunized with a genotype 3 vaccine.
Clinical and experimental vaccine research    July 31, 2020   Volume 9, Issue 2 102-107 doi: 10.7774/cevr.2020.9.2.102
Kim HH, Yang DK, Ji M, Lee SK, Hyun BH.Japanese encephalitis is one of the most important mosquito-borne and zoonotic diseases in Asia and the Pacific region. Although the dominant Japanese encephalitis virus (JEV) genotype has shifted from G3 to G1 in Korea since 1990, a G3 strain (Anyang 300) has been used in vaccines for horses for almost 40 years. This study aimed to investigate the seroconversion rates and geometric mean titers (GMTs) of virus-neutralizing antibodies (VNAs) against JEV G1 and G3 in horses immunized with the G3 vaccine. Methods: Serum samples of 1,231 horses immunized with the Anyang 300 vaccine were collected ...
Prevalence of Ca Blood Type and Alloantibodies in a Population of Horses from Italy.
Animals : an open access journal from MDPI    July 13, 2020   Volume 10, Issue 7 doi: 10.3390/ani10071179
Proverbio D, Perego R, Baggiani L, Ferrucci F, Zucca E, Nobile F, Spada E.A knowledge of the blood groups and alloantibodies present is essential for the safe transfusion of blood products in horses. Pre-transfusion screening and blood typing minimizes the risk of incompatible RBC transfusions and prevents immunization of the recipient against incompatible RBC antigens. The frequencies of blood groups can vary among different breeds. Knowledge of a breed's blood group prevalence can be very useful for identifying the best blood donors during transfusion in clinical practice. The aims of this study were to estimate the prevalence of the Ca blood type in horses from I...
Acrosomal marker SP-10 (gene name Acrv1) for staging of the cycle of seminiferous epithelium in the stallion.
Theriogenology    July 6, 2020   Volume 156 214-221 doi: 10.1016/j.theriogenology.2020.06.046
Cruz A, Sullivan DB, Doty KF, Hess RA, Canisso IF, Reddi PP.The acrosome plays a critical role in sperm-oocyte interactions during fertilization. SP-10 is an acrosomal matrix protein, which is evolutionarily conserved among mammals. The SP-10 antibody has been shown to be useful for staging the seminiferous cycle in the mouse and human. A canonical acrosomal marker; however, has never been used for staging in the horse. The objectives of the present study were to investigate the presence of SP-10 within the horse acrosome using an anti-mouse SP-10 antibody, to classify spermatids based on the shape of the acrosome, and then to use that information to a...
SpeS: A Novel Superantigen and Its Potential as a Vaccine Adjuvant against Strangles.
International journal of molecular sciences    June 23, 2020   Volume 21, Issue 12 4467 doi: 10.3390/ijms21124467
Dominguez-Medina CC, Rash NL, Robillard S, Robinson C, Efstratiou A, Broughton K, Parkhill J, Holden MTG, Lopez-Alvarez MR, Paillot R, Waller AS.Bacterial superantigens (sAgs) are powerful activators of the immune response that trigger unspecific T cell responses accompanied by the release of proinflammatory cytokines. () and () produce sAgs that play an important role in their ability to cause disease. Strangles, caused by , is one of the most common infectious diseases of horses worldwide. Here, we report the identification of a new sAg of , SpeS, and show that mutation of the putative T cell receptor (TCR)-binding motif (YAY to IAY) abrogated TCR-binding, whilst maintaining interaction with major histocompatibility complex (MHC) c...
Intramuscular vaccination with Strangvac is safe and induces protection against equine strangles caused by Streptococcus equi.
Vaccine    June 2, 2020   Volume 38, Issue 31 4861-4868 doi: 10.1016/j.vaccine.2020.05.046
Robinson C, Waller AS, Frykberg L, Flock M, Zachrisson O, Guss B, Flock JI.The equine disease strangles, caused by Streptococcus equi, remains a major cause of welfare and economic cost to the global horse industry. Here we report the safety, immunogenicity and efficacy of a novel multi-component chimeric fusion protein vaccine, called Strangvac, when administered to ponies via the intramuscular route. Across the four studies, Strangvac was safe and induced robust antibody responses towards the vaccine components in blood serum and the nasopharynx, which were boosted by revaccination up to 12 months after a primary course of 2 vaccinations 4 weeks apart. The vaccin...
1 3 4 5 6 7 31